The European healthcare and medical technology mergers and acquisitions sector is navigating a structural transformation of lasting significance. In the first half of 2025, the market demonstrated a striking divergence in its transactional metrics: overall deal value spiked by 87% to reach €31.8 Billion, even as the total deal count contracted by 8% to 418 transactions compared to the same period in the prior year.

The execution of private equity buy-and-build strategies within the highly fragmented European medical technology distribution sector has reached a new level of scale and complexity. On June 2nd 2026, Nordic private equity firm Axcel announced the simultaneous acquisition of four distinct regional distributors to establish Sanviva, a newly consolidated European medical device distribution network. By pulling Apodan (Denmark), PartnerMed (Norway), AllweCare Medical (Netherland